A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults. (Q44195752)
Jump to navigation
Jump to search
scientific article published in August 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults. |
scientific article published in August 2003 |
Statements
A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults (English)
Jacob P Lalezari
Edwin DeJesus
Donald W Northfelt
Gary Richmond
Peter Wolfe
Richard Haubrich
David Henry
William Powderly
Stephen Becker
Melanie Thompson
David Wright
Margrit Carlson
Sharon Riddler
Frances F Haas
Ralph DeMasi
Prokash R Sista
Miklos Salgo
John Delehanty